Forest Namenda Has 10% Off-Label Use In Mild-To-Moderate Alzheimer’s
Forest's Alzheimer's disease agent Namenda has 10% off-label use based on early launch data
Forest's Alzheimer's disease agent Namenda has 10% off-label use based on early launch data